Animal Health Market Size, Share and Forecast 2026-2034

Market Overview:

According to IMARC Group's latest research publication, "Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034", The global animal health market size reached USD 40.1 Billion in 2025 and is projected to reach USD 51.6 Billion by 2034, at a CAGR of 2.73% during 2026-2034.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How the Animal Health Market is Evolving Across the Globe

• North America dominates the global animal health market with a commanding share of 44.9% in 2025, supported by a large pet-owning population, advanced pharmaceutical research infrastructure, and strong government regulations promoting animal welfare and biosecurity.

• Pharmaceuticals lead the product type segment with a 57.0% share in 2025, driven by continuous R&D investments in species-specific medications, controlled-release formulations, and tailored treatment solutions for both companion animals and livestock.

• The United States accounts for 86.50% of the animal health market share within North America, propelled by rising pet adoption rates, growing demand for canine dermatology treatments, and increased focus on food safety linked to livestock health.

• In September 2024, Elanco announced the FDA approval and commercial launch of Zenrelia (ilunocitinib tablets), a targeted treatment for canine dermatological conditions, offering a safer and more effective management option for affected dogs.

• In October 2024, the Indian government announced a USD 25 million G20 Pandemic Fund to enhance livestock health coverage in response to pandemic threats, to be executed in partnership with the Asian Development Bank, World Bank, and FAO, with completion targeted by August 2026.

Download a sample PDF of this report: https://www.imarcgroup.com/animal-health-market/requestsample

Key Trends in the Animal Health Market

• Increasing Focus on Preventive Healthcare: The animal health industry is witnessing a significant shift toward preventive healthcare practices for both companion animals and livestock. Pet parents and livestock producers are recognizing the importance of early detection and proactive disease management to improve overall animal well-being. The Government of India launched the Livestock Health and Disease Control Schemes with a budget of Rs. 525 crore to manage critical livestock diseases and improve animal health nationwide. Additionally, diseases cause 10-15% of production losses in livestock operations, making preventive care a direct economic imperative for farmers and producers globally.

• Advancements in Biotechnology and Pharmaceuticals: The animal health industry is experiencing swift progress in biotechnology and pharmaceuticals, changing how diseases in animals are diagnosed and treated. Advanced technologies including gene editing, cell therapies, polymerase chain reaction (PCR), and DNA sequencing are providing solutions for previously difficult-to-treat conditions. Biotechnology is also enabling the development of sophisticated imaging technologies such as MRI and CT scans, offering comprehensive information about internal structures and irregularities in both pets and livestock, facilitating faster and more accurate diagnoses.

• Growing Pet Humanization and Specialty Pet Care: The relationship between humans and pets continues to evolve toward humanization, creating a significant transformation in consumer behavior across the pet care market. In the United States, 35% of young adults aged 24 to 35 have either adopted a pet or intend to do so in the near future, and 19% adopted a new pet during the COVID-19 lockdown period. Pet parents are increasingly willing to spend more on premium and specialized care products and services, including activity tracking collars, personalized treatments, and advanced veterinary consultations, particularly among the millennial and Gen Z demographics.

• Rising Awareness of Zoonotic Disease Control: Growing outbreaks of zoonotic infections are encouraging investments in vaccines, diagnostics, and antimicrobial therapies for disease control across both companion and commercial animal categories. Governments are implementing stricter regulations and surveillance programs to monitor and prevent zoonotic disease transmission. Mexico's Ministry of Health published its National Health Promotion Days plan with specific guidelines for zoonosis prevention and control, reflecting the One Health framework that addresses brucellosis, rabies, and porcine tapeworm spread.

• Expansion of Veterinary Telemedicine and Digital Health Platforms: The integration of digital technologies is enhancing disease monitoring, outbreak prediction, and real-time data sharing across the veterinary sector. Veterinary service providers are expanding telemedicine and digital health platforms to improve accessibility and treatment outcomes, particularly in remote and underserved regions. In the United Kingdom, 100,000 dogs are currently fitted with activity monitoring devices, highlighting the increasing use of digital health tools by pet owners to proactively manage and track the wellness of their animals.

The global animal health market size 2025 reflects strong growth driven by rising demand for livestock productivity, pet healthcare, and disease prevention. Advancements in veterinary pharmaceuticals and increasing awareness of animal welfare are further boosting market development.

Growth Factors in the Animal Health Market

• Rising Pet Adoption Rates Driving Companion Animal Care Demand: In 2024, 66% of U.S. households have adopted a pet, creating sustained demand for veterinary products, diagnostics, and pharmaceutical solutions tailored to companion animal health. This growing base of pet parents is actively seeking high-quality veterinary care, specialized treatments, and preventive health solutions, directly expanding the market for animal health products and services across North America and beyond.

• Expanding Livestock Sector and Meat Production Fueling Demand in Asia Pacific: Countries like China and India are experiencing high population growth, generating substantial demand for animal protein. India's total meat production during 2023-24 was estimated at 10.25 million tons, reflecting a 4.85% increase over the past decade. This expanding livestock sector is directly increasing the need for vaccines, pharmaceuticals, feed additives, and hygiene solutions to ensure the health and productivity of commercial animal operations.

• Strong Livestock Export Economies Supporting Animal Health Investments in Latin America: Brazil exported 5.138 million tons of poultry products in 2023, making the country one of the world's largest meat and poultry exporters. The need to maintain export-grade product quality and comply with international food safety standards is directly incentivizing producers in Brazil, Argentina, and Mexico to invest in advanced animal health solutions, veterinary care, and disease prevention systems.

• Institutional Investments Strengthening Animal Health Infrastructure: The Asian Development Bank invested USD 10 million in Zenex Animal Health India Private Limited to improve the production and distribution of animal healthcare products, aiming to reduce livestock disease risks and improve farmer incomes. Such institutional backing is reinforcing the development of organized animal health supply chains in emerging economies, making quality products more accessible to smallholder farmers across Asia Pacific.

• Europe's Regulatory Framework and Livestock Population Driving Veterinary Spending: In 2023, Spain held 25.4% of the EU's pig population and 23.6% of its sheep population, while Greece accounted for 25.8% of the EU's goats and France held 22.8% of its bovine population. Europe's well-established regulatory standards for food safety and animal welfare, combined with this substantial livestock base, are driving consistently high expenditure on veterinary care, vaccines, and animal pharmaceuticals across the region.

Leading Companies Operating in the Global Animal Health Industry:

• Bayer

• Elanco

• Merck

• Merial

• Zoetis Inc.

• Biogenesis Bago

• Boehringer Ingelheim

• Ceva Sante Animale

• Heska

• Neogen

• Novartis

• Thermo Fisher Scientific

• Vetoquinol

• Virbac

Animal Health Market Report Segmentation:

Breakup By Animal Type:

• Commercial

• Companion

The commercial segment, which encompasses livestock and poultry reared for dairy, meat, and eggs, is driven by rising demand for animal-derived products and a growing focus on herd health management, biosecurity, and productivity optimization among producers and farming enterprises worldwide.

Breakup By Product Type:

• Pharmaceuticals

• Biologicals

• Medicinal Feed Additives

• Diagnostics

Pharmaceuticals dominate the product type segment with a 57.0% share in 2025, owing to their broad applicability across species, the ongoing development of targeted medications, and significant R&D investment by leading veterinary pharmaceutical companies in disease prevention and chronic illness management.

Breakup By Region:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

North America holds the largest market share of 44.9% in 2025, driven by a large and growing pet-owning population, an advanced livestock production sector, leading pharmaceutical companies investing heavily in innovation, and robust government frameworks promoting animal welfare, food safety, and antimicrobial stewardship across the region.

Recent News and Developments in the Animal Health Market

• January 2025: Ceva Animal Health announced that it has secured the rights to produce and commercialize future products using Touchlight's dbDNA technology in the animal health sector. Led by a global expert in vaccines, Ceva and Touchlight aim to develop a program for creating innovative DNA vaccines for animal health applications.

• November 2024: MSD Animal Health, a division of Merck and Co., declared that the European Commission approved BRAVECTO TriUNO, a new chewable tablet for dogs formulated with fluralaner that targets both internal and external parasites simultaneously.

• October 2024: The Indian government announced a USD 25 million G20 Pandemic Fund aimed at enhancing livestock health coverage in response to pandemic threats like COVID-19. The fund will improve animal health security through laboratory upgrades and network enhancements, and is to be completed by August 2026 in partnership with the Asian Development Bank, World Bank, and FAO.

• September 2024: Elanco announced the FDA approval and commercial launch of Zenrelia (ilunocitinib tablets), a new targeted treatment for canine dermatology conditions, offering an effective and safe option for managing dermatologic diseases and improving the quality of life for affected dogs across the United States.

• February 2024: Merck Animal Health acquired Elanco Animal Health's aqua business outside the United States and Canada for USD 1.3 Billion. The acquisition includes a portfolio of medicines, vaccines, nutritional products, and supplements for aquatic species, along with manufacturing facilities in Canada and Vietnam and a research facility in Chile.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302